Skip to content
Biodatica
Start free

Investigator

John C. Byrd

UNIVERSITY OF CINCINNATI · funded by NCI

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$7.6M

Summed across those awards.

First award
Sep 10, 1997

Latest May 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Pharmacodynamically directed targeted therapy for leukemia

    $683k

    May 1, 2025NCIUNIVERSITY OF CINCINNATINIH RePORTER · 11130087 (opens the source filing in a new tab)

  2. UG1

    ITSC for Leukemia: Novel Molecular strategies for NCTN "Individualized" Therapies

    $633k

    Apr 3, 2019NCIUNIVERSITY OF CINCINNATINIH RePORTER · 11250349 (opens the source filing in a new tab)

  3. P30

    Cancer Center Support Grant

    $6.2M

    Sep 10, 1997NCIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11364434 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources